Diagnostics News and Research

RSS

Researchers identify top-performing COVID-19 POC tests

After screening more than 1,100 independently assessed, point-of-care COVID-19 tests, researchers at NSF International and Novateur Ventures have identified 5 direct (antigen/RNA) tests for detection of acute infection and 6 indirect (antibody) tests for detection of prior infection that meet the recently published World Health Organization (WHO) "desirable" Target Product Profile (TPP) criteria.

10 Feb 2021

Tecan and UgenTec partner to offer sample-to-result solutions for qPCR

Tecan and laboratory software specialist UgenTec have announced a collaboration to develop fully integrated, sample-to-result solutions for PCR workflows.

From Tecan 9 Feb 2021

Compound isolated from Ophiura sarsii can be used as an affordable drug for photodynamic therapy

An unusual biologically active porphyrin compound was isolated from seabed dweller Ophiura sarsii. The substance might be used as an affordable light-sensitive drug for innovative photodynamic therapy and for targeted treatment of triple-negative breast cancer and some other cancers.

8 Feb 2021

FDA continues to support the development of medical products to tackle new virus variants

As the public health agency responsible for regulating medical products, we must ensure that health care providers have the most up-to-date diagnostics, treatments and vaccines in their toolbox to fight this pandemic.

5 Feb 2021

AI technology can help prevent adverse effect of immunotherapy in certain lung cancer patients

Researchers at Case Western Reserve University, using artificial intelligence (AI) to analyze simple tissue scans, say they have discovered biomarkers that could tell doctors which lung cancer patients might actually get worse from immunotherapy.

5 Feb 2021

Gene panel test enables highly accurate diagnosis of liposarcomas

Researchers have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma.

5 Feb 2021

Army scientists evaluate three nonhuman primate models of SARS-CoV-2 airborne infection

Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.

5 Feb 2021

European Union funds new project to improve personalized treatments for ovarian cancer

The European Union has funded a project to improve personalized treatments for ovarian cancer with nearly 15 million euros for five years. The international DECIDER project has partners from 14 organizations in seven EU countries.

5 Feb 2021

Better design of deep learning studies can lead to faster transformation of medical practices

A new Perspective article in Nature Reviews Cancer discusses reasons for the moderate progress and describes remedies designed to facilitate the transition to the clinic.

5 Feb 2021

Researchers to create computational models to improve treatments for ovarian cancer

The 5-year research project involves 14 organizations in seven EU countries and is funded by €15 M from the EU.

4 Feb 2021

European biotech companies rely on AI to deliver COVID-19 vaccine

A high-standard health system, rich health data and a strong research and innovation ecosystem are Europe's key assets that can help transform its health sector and make the EU a global leader in health-related artificial intelligence applications.

4 Feb 2021

New technology could accelerate development of on-chip diagnostic techniques

New technology developed by the University of Bristol has the potential to accelerate uptake and development of on-chip diagnostic techniques in parts of the world where rapid diagnoses are desperately needed to improve public health, mortality and morbidity.

4 Feb 2021

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

NeuroVision Imaging Inc., announced today it has received an investment from the Alzheimer's Drug Discovery Foundation to support developing reliable, affordable biomarker tests for Alzheimer's disease and other forms of dementia and neurodegenerative disorders.

3 Feb 2021

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

World-first 3D printed esophageal stents developed by the University of South Australia could revolutionize the delivery of chemotherapy drugs to provide more accurate, effective and personalized treatment for patients with esophageal cancer.

3 Feb 2021

Genetic changes linked to neurodevelopmental disabilities, cerebral palsy

Researchers have discovered a strong link between genetic changes known to cause neurodevelopmental disabilities and cerebral palsy.

2 Feb 2021

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

A combination of genetic mutations may explain the higher incidence of and poorer outcomes from pediatric leukemia in Hispanic and Latino children, according to Penn State College of Medicine researchers.

2 Feb 2021

Study identifies triggers for acute decompensation of liver cirrhosis

Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.

2 Feb 2021

VirtaMed launches surgical gynecology simulation suite

VirtaMed has the world leading validated simulator for hysteroscopy training, and an innovative solution for the acquisition of laparoscopic skills.

From VirtaMed 2 Feb 2021

Albumin: The Natural Choice for Diagnostic Tests

The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease

From Albumedix Ltd. 2 Feb 2021

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries

Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment.

1 Feb 2021

Diagnostics News and Research

Researchers identify top-performing COVID-19 POC tests

Tecan and UgenTec partner to offer sample-to-result solutions for qPCR

Compound isolated from Ophiura sarsii can be used as an affordable drug for photodynamic therapy

FDA continues to support the development of medical products to tackle new virus variants

AI technology can help prevent adverse effect of immunotherapy in certain lung cancer patients

Gene panel test enables highly accurate diagnosis of liposarcomas

Army scientists evaluate three nonhuman primate models of SARS-CoV-2 airborne infection

European Union funds new project to improve personalized treatments for ovarian cancer

Better design of deep learning studies can lead to faster transformation of medical practices

Researchers to create computational models to improve treatments for ovarian cancer

European biotech companies rely on AI to deliver COVID-19 vaccine

New technology could accelerate development of on-chip diagnostic techniques

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

Genetic changes linked to neurodevelopmental disabilities, cerebral palsy

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

Study identifies triggers for acute decompensation of liver cirrhosis

VirtaMed launches surgical gynecology simulation suite

Albumin: The Natural Choice for Diagnostic Tests

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News